CardioComm Solutions (Toronto) announced today that it is working with startup Zana Technologies (Karlsruhe, Germany) to package CardioComm’s ECG reviewing and monitor technology into Zana’s mobile app and patient engagement platform.
The goal is for Zana users to be able to download a single smartphone app over which they can receive ECG recordings and clinical feedback through Zana’s cloud-based patient engagement platform — with CardioComm’s hospital ECG management software technologies incorporated into the system.
The companies plan to test out CardioComm’s GEMS ECG reviewing and HeartCheck ECG monitoring technologies along with Zana in multiple medical centers throughout Europe. Zana officials would like to see the company become a preferred vendor for telemedicine solutions for monitoring a patient’s post-hospital discharge.
Zana’s patient engagement platform uses an intelligent, voice-based assistant with interactive and learning technologies, enabling home-based, continuous health monitoring to improve people’s health outcomes.
Other companies are also active in the mobile ECG space. Mountain View, Calif.–based AliveCor, for example, has its KardiaBand, a wrist-worn device that is designed to detect atrial fibrillation, and the KardiaMobile app, a clinical-grade monitor that uses fingerpads to generate an ECG. AliveCor raised $6 million in equity financing in October.